// STARTUP COMPARISON
Theranos fraud vs Ynsect
Theranos fraud failed in 2018 due to Fraud. Ynsect failed in 2024 due to Unit Economics. Different causes, different sectors, different eras — but the same simulation outcome.
| METRIC | 🔥 Theranos fraud | 🔥 Ynsect |
|---|---|---|
| Sector | Biotech | Biotech |
| Country | USA | France |
| Founded | 2003 | 2011 |
| Died | 2018 | 2024 |
| Raised | $945M | €450M |
| Peak | $9B | €1.7B valuation (2021) |
| Primary Cause | Fraud | Unit Economics |
// WHY EACH FAILED
🔥 Theranos fraud
Fraud
See theranos entry.
// LESSON
See theranos entry.
See theranos entry.
🔥 Ynsect
Unit Economics
Ynsect built vertical farms to breed mealworms for animal feed — positioning it at the intersection of sustainability, food security, and deep tech. It raised €450M and reached a €1.7B valuation. The problem was unit economics: its €200M flagship farm in Amiens required 18 months to reach full capacity and even at full capacity produced mealworm protein at €4/kg — vs. soybean meal at €0.45/kg. The 9× cost premium was not offset by sustainability positioning in commodity feed markets. Unable to achieve cost parity, Ynsect entered court-ordered restructuring (redressement judiciaire) in February 2024.
// LESSON
Sustainability is not a price premium in commodity markets. Animal feed buyers optimize for cost per gram of protein. If your insect protein costs 9× soybean meal, no amount of ESG storytelling closes that gap at B2B scale.
Sustainability is not a price premium in commodity markets. Animal feed buyers optimize for cost per gram of protein. If your insect protein costs 9× soybean meal, no amount of ESG storytelling closes that gap at B2B scale.
// EXPLORE FURTHER